ICAM2 and rheumatoid arthritis: For example, modification of m6A methylation of ICAM2 mRNA by artemisitene resulted in a 55–70% reduction in ICAM2 expression and p-AKT levels, accompanied by a marked decrease in proliferation and migration of RA-FLSs [46].